儿科外体疗法的药物动力学研究:现状和未来方向
Gideon Stitt1, Céline Thibault2,3, Bruce A Mueller4
1Center for Clinical Pharmacology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Blood purification
|October 4, 2024
概括
优化药物剂量对于关键病的儿童在体外生命支持 (ECLS),包括ECMO和CRRT,至关重要. 专家建议优先考虑特定药物和加强研究方法,以改善患者的治疗结果.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 药理动力学和药物的剂量.
- 身体外生命支持 (ECLS)
背景情况:
- 身体外生命支持 (ECLS),包括ECMO和CRRT,拯救了重症儿童,但死亡率很高.
- 由于疾病和患者电路相互作用而改变药物处置,导致ECLS儿童的治疗结果不佳.
- 在ECLS的儿童接受多种药物,通常没有建立最佳剂量指南.
研究的目的:
- 总结了儿童体外和体外疗法峰会 (PPETS) 的结论.
- 为优化儿科ECLS群体的药理动力学 (PK) 研究提出一个框架.
- 确定未来PK研究的高优先级药物,以改善药物使用和患者的治疗结果.
主要方法:
- 在PPETS峰会上召集了ECLS,ECMO和CRRT的国际专家.
- 综合了关于当前ECLS疗法,支持策略和临床经验的专家讨论.
- 根据使用频率,不良事件潜力和数据稀缺性,为PK研究优先选择药物.
主要成果:
- 达成共识,需要优先考虑在儿科ECLS中进行PK研究的特定药物.
- 确定了未来PK研究的关键方法考虑因素,包括多中心研究和创新的建模.
- 编制了一份需要进一步 PK 调查的高优先级药物清单.
结论:
- 在儿科ECLS中优化药物剂量对于改善患者存活率至关重要.
- 未来的研究必须专注于高优先级的药物,并采用先进的PK研究设计和建模.
- 将验证的PK模型集成到临床实践中对于在床边提供最佳药物治疗至关重要.
相关概念视频
01:26Pharmacokinetic Models: Comparison and Selection Criterion
48
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
48
01:20Pharmacokinetic Models: Overview
607
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
607
01:12Analysis of Population Pharmacokinetic Data
237
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
237
01:10Pharmacokinetics: Overview
5.8K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
5.8K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
34
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
34
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51